Increasing the Proportional Content of Surfactant (Cremophor EL) Relative to Lipid in Self-emulsifying Lipid-based Formulations of Danazol Reduces Oral Bioavailability in Beagle Dogs
article
OA: closed
CC0
⤵ 8 in-corpus citations
Limited metadata. Only one source feed has indexed
this record so far — no abstract, full text, or open-access copy is
available through Endo Lab. The
publisher's page (linked below)
is the canonical location for the actual content. If you have institutional
access, use "Find at my library".
My notes (saved in your browser only)
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (49)
- A dynamic in vitro lipolysis model via openalex
- In vivo in vitro correlations for a poorly soluble drug, danazol, using the flow-through dissolution method with biorelevant dissolution media via openalex
- Relative bioavailability of danazol in dogs from liquid-filled hard gelatin capsules via openalex
- Solubilization and Wetting Effects of Bile Salts on the Dissolution of Steroids via openalex
- Susceptibility to Lipase-Mediated Digestion Reduces the Oral Bioavailability of Danazol After Administration as a Medium-Chain Lipid-Based Microemulsion Formulation via openalex
- doi:10.1016/s0022-2275(20)36977-7 via openalex
- W2417194615 via openalex
- W2433102311 via openalex
- doi:10.1016/s0169-409x(96)00489-9 via openalex
- doi:10.1007/bf02535343 via openalex
- doi:10.1016/j.ijpharm.2003.12.028 via openalex
- doi:10.1007/s11095-006-9054-x via openalex
- doi:10.1248/bpb.27.1993 via openalex
- doi:10.1016/j.clpt.2004.09.001 via openalex
- doi:10.1016/s0928-0987(01)00169-5 via openalex
- doi:10.1046/j.1365-2125.2002.01595.x via openalex
- doi:10.1111/j.2042-7158.1974.tb09349.x via openalex
- doi:10.1016/s0168-3659(00)00343-6 via openalex
- doi:10.1002/jps.10554 via openalex
- doi:10.1016/s0378-5173(97)00248-2 via openalex
- doi:10.1016/0378-5173(94)00222-q via openalex
- doi:10.1023/a:1016033702220 via openalex
- doi:10.1002/jps.20039 via openalex
- doi:10.1111/j.2042-7158.1974.tb10674.x via openalex
- doi:10.1016/0378-5173(94)90271-2 via openalex
- doi:10.1016/0378-5173(85)90081-x via openalex
- doi:10.1016/j.biopha.2004.02.001 via openalex
- doi:10.1016/j.ejps.2004.08.003 via openalex
- doi:10.1023/a:1018987928936 via openalex
- doi:10.1016/j.ijpharm.2005.02.038 via openalex
- doi:10.1016/s0378-5173(99)00367-1 via openalex
- doi:10.1016/s0378-5173(00)00614-1 via openalex
- doi:10.1016/s0378-5173(98)00054-4 via openalex
- doi:10.1023/a:1016268311867 via openalex
- doi:10.1023/a:1015987223407 via openalex
- doi:10.1002/jps.10329 via openalex
- doi:10.1021/bi00460a011 via openalex
- doi:10.1211/0022357021771896 via openalex
- doi:10.1016/s0939-6411(00)00089-8 via openalex
- doi:10.1211/jpp.58.6.0011 via openalex
- doi:10.1211/0022357022872 via openalex
- doi:10.1016/j.jconrel.2005.10.002 via openalex
- doi:10.1081/ddc-100101263 via openalex
- doi:10.1016/s0169-409x(96)00494-2 via openalex
- doi:10.1016/j.ijpharm.2004.08.024 via openalex
- doi:10.1016/s0731-7085(00)00528-8 via openalex
- doi:10.1016/s0169-409x(01)00182-x via openalex
- doi:10.1016/s0022-2275(20)39696-6 via openalex
- doi:10.1021/js970300n via openalex
Cited by (8)
- Danazol 2022
- An in Vitro Digestion Test That Reflects Rat Intestinal Conditions To Probe the Importance of Formulation Digestion vs First Pass Metabolism in Danazol Bioavailability from Lipid Based Formulations 2014
- Non-linear Increases in Danazol Exposure with Dose in Older vs. Younger Beagle Dogs: The Potential Role of Differences in Bile Salt Concentration, Thermodynamic Activity, and Formulation Digestion 2014
- Application of Capmul MCM and caprylic acid for the development of danazol-loaded SEDDS 2014
- Evaluation of a Nanoemulsion Formulation Strategy for Oral Bioavailability Enhancement of Danazol in Rats and Dogs 2013
- Incomplete Desorption of Liquid Excipients Reduces the <i>in Vitro</i> and <i>in Vivo</i> Performance of Self-Emulsifying Drug Delivery Systems Solidified by Adsorption onto an Inorganic Mesoporous Carrier 2012
- Lipid-based Formulations for Danazol Containing a Digestible Surfactant, Labrafil M2125CS: In Vivo Bioavailability and Dynamic In Vitro Lipolysis 2008
- Evaluation of the Impact of Surfactant Digestion on the Bioavailability of Danazol after Oral Administration of Lipidic Self-Emulsifying Formulations to Dogs 2007
Source provenance
- openalex
- last seen: 2026-05-11T05:54:30.111693+00:00
License: CC0
· commercial use OK